$402 Million is the total value of Eversept Partners, LP's 61 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HCA | New | HCA HEALTHCARE INC | $9,074,850 | – | 101,000 | +100.0% | 2.26% | – |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $3,986,160 | – | 146,550 | +100.0% | 0.99% | – |
| XLRN | New | ACCELERON PHARMA INC | $3,801,950 | – | 42,305 | +100.0% | 0.94% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $3,620,282 | – | 106,385 | +100.0% | 0.90% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $2,695,557 | – | 90,047 | +100.0% | 0.67% | – |
| GNMK | New | GENMARK DIAGNOSTICS INC | $2,159,939 | – | 524,257 | +100.0% | 0.54% | – |
| ALGN | New | ALIGN TECHNOLOGY INCput | $1,739,500 | – | 10,000 | +100.0% | 0.43% | – |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $1,257,978 | – | 210,013 | +100.0% | 0.31% | – |
| CYCN | New | CYCLERION THERAPEUTICS INC | $893,434 | – | 337,145 | +100.0% | 0.22% | – |
| TARA | New | ARTARA THERAPEUTICS INC | $746,994 | – | 32,478 | +100.0% | 0.19% | – |
| AMRN | New | AMARIN CORP PLCput | $600,000 | – | 150,000 | +100.0% | 0.15% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $491,638 | – | 58,251 | +100.0% | 0.12% | – |
| AL | New | AIR LEASE CORPput | $442,800 | – | 20,000 | +100.0% | 0.11% | – |
| ZGNX | New | ZOGENIX INCcall | $136,015 | – | 5,500 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.